Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
16.02
-0.14 (-0.87%)
Jul 29, 2026, 9:59 AM EDT - Market open

Rallybio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
85294090249307
Market Cap Growth
308.86%-27.23%-55.93%-63.63%-18.90%-
Enterprise Value
38.95-25.56-25.51-19.1280.15131.19
Last Close Price
16.025.497.6819.1252.5676.32

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
99.7633.8062.66---
PB Ratio
1.700.500.650.851.471.75
P/TBV Ratio
1.800.530.680.911.241.39

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
45.40-29.79-40.11---
EV/EBITDA Ratio
-0.780.420.24--
EV/EBIT Ratio
-0.770.420.24--
EV/FCF Ratio
-0.860.520.32--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.0000.000.000
Net Debt / Equity Ratio
-0.93-0.94-1.06-1.03-0.99-1.00
Net Debt / EBITDA Ratio
1.461.661.081.392.493.85
Net Debt / FCF Ratio
1.691.831.331.822.943.82
Asset Turnover
0.010.010.01000
Quick Ratio
11.3012.9610.5011.8715.7326.76
Current Ratio
12.9214.5010.8712.3916.7127.61
Return on Equity (ROE)
-14.44%-15.01%-68.85%-54.13%-38.65%-30.17%
Return on Assets (ROA)
-55.04%-50.72%-65.85%-53.32%-37.44%-28.17%
Return on Invested Capital (ROIC)
-913.74%----11847.12%-
Return on Capital Employed (ROCE)
-59.29%-55.15%-71.92%-57.19%-39.32%-29.29%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-1.50%-3.42%-7.66%-27.11%-24.70%-46.76%
Total Shareholder Return
-1.50%-3.42%-7.66%-27.11%-24.70%-46.76%
SEC Filings: 10-K · 10-Q